“At the local level, companies looking to mitigate the increased costs are using a familiar set of strategies,” the 2023 Global Medical Trends Report from Aon says.
Check out the slideshow to see which states have a handle on health care spending, and which have the most work to do.
The FDA’s accelerated approval is usually based on a “surrogate marker” of effectiveness.
Sponsored by Edelman Financial Engines
Sponsored by Crossover Health
Sponsored by Progyny
- Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
- Exclusive discounts on BenefitsPRO.com and ALM events.
Copyright © 2022 ALM Global, LLC. All Rights Reserved.